These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17224331)

  • 1. Long-term oral lysine supplementation in lysinuric protein intolerance.
    Tanner LM; Näntö-Salonen K; Niinikoski H; Huoponen K; Simell O
    Metabolism; 2007 Feb; 56(2):185-9. PubMed ID: 17224331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral supplementation corrects plasma lysine concentrations in lysinuric protein intolerance.
    Lukkarinen M; Näntö-Salonen K; Pulkki K; Aalto M; Simell O
    Metabolism; 2003 Jul; 52(7):935-8. PubMed ID: 12870174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carnitine deficiency and L-carnitine supplementation in lysinuric protein intolerance.
    Tanner LM; Näntö-Salonen K; Rashed MS; Kotilainen S; Aalto M; Venetoklis J; Niinikoski H; Huoponen K; Simell O
    Metabolism; 2008 Apr; 57(4):549-54. PubMed ID: 18328359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperammonemia in lysinuric protein intolerance.
    Kato T; Mizutani N; Ban M
    Pediatrics; 1984 Apr; 73(4):489-92. PubMed ID: 6424086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lysinuric protein intolerance: a severe hyperammonemia secondary to l-arginine deficiency (author's transl)]].
    Coude FX; Ogier H; Charpentier C; Cathelineau L; Grimber G; Parvy P; Saudubray JM; Frezal J
    Arch Fr Pediatr; 1981 Dec; 38 Suppl 1():829-35. PubMed ID: 6800334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutrient intake in lysinuric protein intolerance.
    Tanner LM; Näntö-Salonen K; Venetoklis J; Kotilainen S; Niinikoski H; Huoponen K; Simell O
    J Inherit Metab Dis; 2007 Oct; 30(5):716-21. PubMed ID: 17588131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal handling of diamino acids in lysinuric protein intolerance.
    Simell O; Perheentupa J
    J Clin Invest; 1974 Jul; 54(1):9-17. PubMed ID: 4600043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of lysine infusion on urea cycle in lysinuric protein intolerance.
    Lukkarinen M; Näntö-Salonen K; Pulkki K; Mattila K; Simell O
    Metabolism; 2000 May; 49(5):621-5. PubMed ID: 10831173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lysinuric protein intolerance].
    Behbehani AW; Gahr M; Schröter W
    Monatsschr Kinderheilkd; 1983 Nov; 131(11):784-7. PubMed ID: 6420670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysinuric protein intolerance.
    Simell O; Perheentupa J; Rapola J; Visakorpi JK; Eskelin LE
    Am J Med; 1975 Aug; 59(2):229-40. PubMed ID: 1155480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imbalance of plasma amino acids, metabolites and lipids in patients with lysinuric protein intolerance (LPI).
    Kurko J; Tringham M; Tanner L; Näntö-Salonen K; Vähä-Mäkilä M; Nygren H; Pöhö P; Lietzen N; Mattila I; Olkku A; Hyötyläinen T; Orešič M; Simell O; Niinikoski H; Mykkänen J
    Metabolism; 2016 Sep; 65(9):1361-75. PubMed ID: 27506743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene.
    Torrents D; Mykkänen J; Pineda M; Feliubadaló L; Estévez R; de Cid R; Sanjurjo P; Zorzano A; Nunes V; Huoponen K; Reinikainen A; Simell O; Savontaus ML; Aula P; Palacín M
    Nat Genet; 1999 Mar; 21(3):293-6. PubMed ID: 10080182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Protein intolerance with lysinuria. Value of orotic aciduria in adjusting treatment with citrulline].
    de Parscau L; Vianey-Liaud C; Hermier M; Divry P; Guibaud P
    Arch Fr Pediatr; 1988 Dec; 45(10):809-12. PubMed ID: 3149174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysinuric protein intolerance: a two-year trial of dietary supplementation therapy with citrulline and lysine.
    Rajantie J; Simell O; Rapola J; Perheentupa J
    J Pediatr; 1980 Dec; 97(6):927-32. PubMed ID: 6777479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperdibasicaminoaciduria, hyperammonemia, and growth retardation: Treatment with arginine, lysine, and citrulline.
    Awrich AE; Stackhouse WJ; Cantrell JE; Patterson JH; Rudman D
    J Pediatr; 1975 Nov; 87(5):731-8. PubMed ID: 1185337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysinuric protein intolerance: reviewing concepts on a multisystem disease.
    Sebastio G; Sperandeo MP; Andria G
    Am J Med Genet C Semin Med Genet; 2011 Feb; 157C(1):54-62. PubMed ID: 21308987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral administration of epsilon N-acetyllysine and homocitrulline in lysinuric protein intolerance.
    Rajantie J; Simell O; Perheentupa J
    J Pediatr; 1983 Mar; 102(3):388-90. PubMed ID: 6402575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysinuric protein intolerance presenting deficiency of argininosuccinate synthetase.
    Ono N; Kishida K; Tokumoto K; Watanabe M; Shimada Y; Yoshinaga J; Fujii M
    Intern Med; 1992 Jan; 31(1):55-9. PubMed ID: 1568044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephropathy advancing to end-stage renal disease: a novel complication of lysinuric protein intolerance.
    Tanner LM; Näntö-Salonen K; Niinikoski H; Jahnukainen T; Keskinen P; Saha H; Kananen K; Helanterä A; Metso M; Linnanvuo M; Huoponen K; Simell O
    J Pediatr; 2007 Jun; 150(6):631-4, 634.e1. PubMed ID: 17517249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.